Guardant Health Net Income 2017-2022 | GH

Guardant Health net income from 2017 to 2022. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Guardant Health Annual Net Income
(Millions of US $)
2021 $-406
2020 $-254
2019 $-76
2018 $-85
2017 $-89
2016 $-46
Guardant Health Quarterly Net Income
(Millions of US $)
2022-03-31 $-123
2021-12-31 $-91
2021-09-30 $-108
2021-06-30 $-98
2021-03-31 $-110
2020-12-31 $-94
2020-09-30 $-78
2020-06-30 $-55
2020-03-31 $-28
2019-12-31 $-25
2019-09-30 $-13
2019-06-30 $-12
2019-03-31 $-26
2018-12-31 $-25
2018-09-30 $-24
2018-06-30 $-22
2018-03-31 $-14
2017-12-31
2017-09-30 $-33
2016-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.926B $0.374B
Guardant Health Inc. is a precision oncology company. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. The company's Guardant Health Oncology Platform is designed for clinical development, regulatory and reimbursement to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs. It launched multiple liquid biopsy-based tests, Guardant360 and GuardantOMNI, for advanced stage cancer patients, which fuel its development programs for recurrence and early detection, LUNAR-1 and LUNAR-2. Guardant Health Inc. is based in REDWOOD CITY, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $165.194B 10.05
Bio-Rad Laboratories (BIO.B) United States $15.121B 32.79
QIAGEN (QGEN) Netherlands $10.361B 16.35
Biohaven Pharmaceutical Holding (BHVN) United States $10.098B 0.00
Ginkgo Bioworks Holdings (DNA) United States $5.208B 0.00
Emergent Biosolutions (EBS) United States $1.617B 6.92
Arcus Biosciences (RCUS) United States $1.305B 33.09
Myovant Sciences (MYOV) United Kingdom $0.956B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.500B 0.00
Zymeworks (ZYME) Canada $0.368B 0.00
Gelesis Holdings (GLS) United States $0.349B 0.00
Ambrx Biopharma (AMAM) United States $0.154B 0.00
Enzo Biochem (ENZ) United States $0.108B 22.10
SQZ Biotechnologies (SQZ) United States $0.097B 0.00